Skip to content
Medical Health Aged Care

Sapyen’s World First Laboratory-Grade Home Fertility Test For Men Hits The Shelves

Sapyen 3 mins read

BRISBANE, Australia, 6th December 2023 - With reports of a rapid decline in sperm counts filling news feeds, Australian born male fertility healthtech, Sapyen, has delivered the first ever laboratory-grade, at-home semen analysis to retail shelves in Australia via Terry White Chemmart Arana Hills.

“Accessing in-clinic testing isn't just embarrassing and expensive; it's also inherently challenging to access for many men due to the 12-month waiting period”. Ashwin Ramachandran, founder of Sapyen said. “At Sapyen, we built a lab-quality male fertility test that's as accessible as a pregnancy test - something men could pick up and do in the comfort of their home, all at a price that is cheaper than going into a lab.” Ramachandran continued.

Sapyen’s patent-pending sperm stabilisation medium, SPX72, is the breakthrough technology that enables a complete at-home solution to testing that is 135.4% more accurate than other competing diagnostics and just a fraction of the cost of in-clinic options^. The SPX72 medium is a fluid that effectively turns sperm into 72 hour endurance swimmers, giving it time to get from your home to a testing facility via your local postie. Without SPX72, sperm needs to be tested within one hour of collection before its quality declines significantly. With a staggering 62.25% of Aussie men unable to get to a collection centre within that timeframe^ due to the scarcity of facilities, this is virtually impossible for men who want or are asked to collect at home.

Adam* knows this all too well, after trying to conceive for 12 months with no success. “We decided to take control and seek out sperm analysis options after we were told to just go away and keep trying for another six months before obtaining a referral for testing, that’s when we came across Sapyen. No one had told us we could do it all from home without having to go into a clinic and have such a comprehensive report delivered to us within three days - it’s been life changing”. 

When trying to conceive, most investigations centre on the woman yet 40-50% of the problems couples face in trying to conceive are due to the man. The simplicity of male fertility testing and the often easy lifestyle changes that can improve sperm quality could help avoid many invasive tests that women are forced to undergo unnecessarily, saving couples thousands of dollars on their journey to have a child.

Karen Brown, owner of Terry White Chemmart pharmacy in Arana Hills Queensland welcomed the Sapyen test kits with open arms “As a pharmacy who is passionate about men’s health we are excited to be the first retail store in Australia to bring this product to our customers. Our highly knowledgeable team is always available in-store to answer questions but equally, for men who want to purchase discreetly, they can still do so online.”

Sapyen offers the most comprehensive at-home male fertility test available for $149, covering all nine fertility parameters conducted at National Association of Testing Authorities (NATA) accredited pathology labs Australia-wide. A personalised report is then received within three days providing results and clear explanations on your next steps, including information for your medical practitioner if further interventions are required. 

Sapyen Test Kits are available now on shelves at Terry White Chemmart Arana Hills store or online at www.sapyen.co/twcm 

-ENDS-



References:

^Data on file
*Name changed due to privacy reasons


Key Facts:

- World first laboratory-grade home fertility test for men now available in pharmacy.

- Breakthrough technology makes male fertility testing as accessible as a pregnancy test.

- 135.4% more accurate than other competing diagnostics.

- Saves couples potentially thousands of dollars in in-clinic testing costs.

- Answers the call of 62.25% of Aussie men who cannot get a sperm sample to a testing site within one hour (as per WHO Guidelines).


About us:

ABOUT SAPYEN

Sapyen is on a mission to make male fertility health more accessible with the world's first complete at-home sperm health and fertility test. Born in Australia and now making considerable global inroads, Sapyen's Test Kit utilises a patent-pending sperm stabilisation medium, SPX72. This breakthrough technology ensures the sample remains at the highest quality as it travels from your home via post to an accredited pathology clinic Australia wide.

No more awkward collection rooms, handing in a filled sample jar in-person, or performance anxiety. Convenient, discreet, cost-effective and accurate, Sapyen offers a total at-home experience that is 135.4% more accurate at a fraction of the cost of other less-comprehensive tests. Sapyen goes another step further with their patient-focused care. Within 72 hours of testing, a personalised report lands directly in your inbox covering all nine key fertility parameters and provides clear explanations on your next steps, including information for your medical practitioner if further interventions are required.


Join the men that have used Sapyen to help take control of their fertility health and future. Visit
www.sapyen.co/twcm to purchase.


Contact details:

For any questions in relation to this release or to discuss interviews, please contact:

Nicole Papoutsis

[email protected]
0422 418 099

 

 

Media

More from this category

  • Medical Health Aged Care, Political
  • 16/01/2026
  • 06:00
Monash University

National genomic screening program would save thousands of Australians from preventable cancer and heart disease

Leadinggenomic health experts from Monash University are calling for urgent government funding to progress the development of a national preventive genomic testing program that would save thousands of Australians from conditions like cancer and heart disease. This call to action follows a Monash-led nationwide pilot study recently completed, offering free genomic screening to 10,000 Australians aged 18 to 40. The pilot tested for 10 medically actionable genes linked to hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolaemia. The findings are published today in the inaugural edition of the new academic journal Nature Health. The pilot study was led…

  • Medical Health Aged Care
  • 16/01/2026
  • 00:11
QPS Holdings, LLC

QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials

NEWARK, Del.–BUSINESS WIRE– QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2026
  • 23:11
WHOOP

WHOOP and Samuel Ross MBE Announce Multiyear, Global Creative Partnership, Introducing a New Era in Performance Fashion

The WHOOP x SR_A collaboration ushers in a new frontier of performance accessories, apparel, and design-driven technology BOSTON–BUSINESS WIRE– WHOOP, the human performance company,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.